| Nov 13 |
CeriBell GAAP EPS of -$1.85, revenue of $17.2M
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 5 |
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
|
| Oct 29 |
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024
|
| Oct 21 |
CeriBell: An Interesting EEG Play Going Public
|
| Oct 16 |
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG
|
| Oct 15 |
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
|
| Oct 14 |
IPO Roundup: Drugs Made in America Acquisition, FBS Global and more
|
| Oct 14 |
Opening Day: Another trio of biotech IPOs make Friday debut
|
| Oct 11 |
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs
|
